Conclusions the relatively high ALT level, low HBV DNA ration and early virus response are the major factors that affect the curative effect of lamivudine in treating chronic hepatitis B.
结论治疗前较高的ALT水平，较低的HBV DNA定量值及出现早期病毒学应答是影响拉米夫定治疗慢性乙型肝炎疗效的主要因素。
Conclusion: Lamivudine treatment could decrease the HBV-DNA and transaminase level, and delay the progression of liver fibrosis and lighten inflammation and necrosis of liver.
结论：拉米夫定治疗慢性乙型肝炎，可以明显降低血清hbv - DNA及转氨酶水平，延缓肝组织纤维化的进展，减轻肝组织的炎症坏死。
Treating with nucleosides plus ALSS could accelerate the amelioration of liver function, shorten course of disease, decrease mortality and HBV DNA level.
核苷类似物联合人工肝治疗可加快肝功能好转，缩短病程，降低病死率，降低血清HBV DNA水平。
Treating with nucleosides plus ALSS could accelerate the amelioration of liver function, shorten course of disease, decrease mortality and HBV DNA level.
核苷类似物联合人工肝治疗可加快肝功能好转，缩短病程，降低病死率，降低血清HBV DNA水平。
应用推荐